SCHEMBL1484236

SCHEMBL1484236

Cc1ccc2cc(-c3cnc4[nH]ccc4c3)[nH]c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK8 P49336 7/20 0.49
AXL P30530 2/20 0.49
ITK Q08881 6/20 0.48
PLK4 O00444 2/20 0.48
ROCK2 O75116 2/20 0.48
PRKD3 O94806 2/20 0.48
MAP4K4 O95819 2/20 0.48
INSR P06213 2/20 0.48
CDK1 P06493 2/20 0.48
ROS1 P08922 2/20 0.48
FER P16591 2/20 0.48
CDK2 P24941 2/20 0.48
MARK3 P27448 2/20 0.48
FLT4 P35916 2/20 0.48
KDR P35968 2/20 0.48
SYK P43405 2/20 0.48
MAPK8 P45983 2/20 0.48
CSNK1D P48730 2/20 0.48
CLK2 P49760 2/20 0.48
BLK P51451 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1484246 0.89 CDK8 (0.49) CDK8AXLITKPLK4ROCK2
SCHEMBL1484606 0.84 CDK8 (0.49) CDK8AXLITKPLK4ROCK2
SCHEMBL13577845 0.84 CDK8 (0.49) CDK8AXLITKPLK4ROCK2
SCHEMBL1484047 0.83 KDR (0.51) CDK8AXLITKPLK4ROCK2
SCHEMBL1484596 0.83 RIPK1 (0.64) CDK8AXLITKPLK4ROCK2
SCHEMBL24067664 0.80 PIK3CD (0.60) CDK8AXLITKPLK4ROCK2
SCHEMBL15871324 0.76 RIPK1 (0.71) CDK8AXLITKPLK4ROCK2
SCHEMBL1422756 0.76 CYP19A1 (0.52) CDK8AXLITKPLK4ROCK2
SCHEMBL13577819 0.76 CDK8 (0.49) CDK8AXLITKPLK4ROCK2
SCHEMBL5038642 0.76 CDK8 (0.55) CDK8AXLITKPLK4ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US claimed
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US disclosed
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US disclosed
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US disclosed
WO-2009155024-A1 NOVEL SUBSTITUTED INDOLES MERCK & CO., INC. (US) 2009-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110076230-A1 Novel Substituted Indoles APP, BACE1, PSEN1 CDK8 4292/4885AXL 3214/4885ITK 2908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.